1. Home
  2. BRAI vs IMTX Comparison

BRAI vs IMTX Comparison

Compare BRAI & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braiin Limited Common Stock

BRAI

Braiin Limited Common Stock

N/A

Current Price

$5.66

Market Cap

1.3B

Sector

N/A

ML Signal

N/A

IMTX

Immatics N.V.

HOLD

Current Price

$9.64

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRAI
IMTX
Founded
N/A
N/A
Country
Australia
Germany
Employees
N/A
407
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BRAI
IMTX
Price
$5.66
$9.64
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$19.00
AVG Volume (30 Days)
515.2K
370.8K
Earning Date
N/A
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$25.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.15
$5.05
52 Week High
$32.32
$12.41

Technical Indicators

Market Signals
Indicator
BRAI
IMTX
Relative Strength Index (RSI) 45.22 52.32
Support Level $5.15 $8.86
Resistance Level $7.55 $10.67
Average True Range (ATR) 0.64 0.52
MACD 0.11 0.05
Stochastic Oscillator 20.48 80.84

Price Performance

Historical Comparison
BRAI
IMTX

About BRAI Braiin Limited Common Stock

Braiin Ltd is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (AI/ML) technologies to deliver actionable insights across the verticals: Agriculture, Property Technology, and Customer Experience as a Service (CXaaS). The company's platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. It prominently focuses on the agriculture technology sector, where it has successfully deployed its AI-powered solutions across multiple implementations. It provides end-to-end solutions to improve farming productivity using IoTs, Wireless Connectivity, Robotics, Software and AI/ML.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: